Boguszewski MCS, Boguszewski CL, Chemaitilly W, Cohen LE, Gebauer J, Higham C, et al
Typical schedule Many people use a weekly start phase, then maintenance injections every 46 weeks (subject to clinician review)
Datos toxicolgicos preclnicos: Los estudios de toxicidad aguda y subaguda en la rata no han evidenciado mortalidad ni toxicidad orgnica significativa, incluso a dosis ampliamente superiores a las dosis teraputicas (hasta 100 veces la dosis eficaz)
Related compounds Explore related research peptides Ready to order GHK-Cu
The questions most people have about IV therapy are practical ones: whats actually in the formula, what will it do for the body, and how does it compare to other options